Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|November 1, 2017
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform researchLiza J McCann, Clarissa A Pilkington, Adam M Huber, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
JCI Insight|January 17, 2020
Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathiesNickie Seto, Jose Jiram Torres-Ruiz, Carmelo Carmona-Rivera, et al.
Annals of the Rheumatic Diseases|May 2, 2023
Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodiesIago Pinal-Fernandez, Jose Cesar Milisenda, Katherine Pak, et al.
Lancet (London, England)|January 11, 2025
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trialDavid Fiorentino, Aaron R Mangold, Victoria P Werth, et al.
Annals of the Rheumatic Diseases|February 21, 2023
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositisIago Pinal-Fernandez, Angela Quintana, Jose Cesar Milisenda, et al.
Clinical and Experimental Rheumatology|March 4, 2024
Collaborative research in myositis-related disorders: MIHRA, a global shared community modelLesley Ann Saketkoo, Julie J Paik, Helene Alexanderson, et al.
Annals of the Rheumatic Diseases|June 20, 2024
Pathological autoantibody internalisation in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
Pathogenic autoantibody internalization in myositisIago Pinal-Fernandez, Sandra Muñoz-Braceras, Maria Casal-Dominguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2021
Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune DiseasesKathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, et al.
Pageof 18